Supporting scientific research
The Hanarth Fonds was founded on September 28, 2018, using the legacy of Arthur del Prado, founder and former CEO of ASM International. The fund aims to promote and enhance the use of artificial intelligence and machine learning to improve the diagnosis, treatment and outcome of patients with cancer. Therefore the Hanarth Fonds supports scientific research that focuses on primarily, but not exclusively, rare types of cancer.
Targeted applicants are clinicians or scientists with a background in oncology and an interest in artificial intelligence and machine learning joined with a partner or partners with a background in artificial intelligence and machine learning and an interest in oncology.
The Hanarth Fonds has with two types of financing
This website will give you more information on the fund, the organization and the possibilities, conditions and procedure of funding. You can also apply for funding on this website.
8 October 2026
Hanarth Fund Symposium 2026 Programme Announced
On 26 November 2026, the Hanarth Fund will organise its symposium on artificial intelligence in oncology. The programme, featuring speakers and presentations of research projects, is now available.
Read more >
28 September 2026
Changes to the Board of the Hanarth Fund
The Hanarth Fund has announced changes to the composition of its Board. This transition marks a new step in the Fund’s continued development and its commitment to supporting scientific research into rare forms of cancer.
Read more >
30 April 2026
€40 million for AI4Health: Foundations Join Forces for Better Healthcare Through AI
The Hanarth Fund is investing in AI4Health alongside other health foundations, a ten-year national programme that uses artificial intelligence to accelerate innovation in healthcare and improve patient care.
Read more >